Themis Medicare informs about outcome of board meeting

28 Jul 2022 Evaluate

Themis Medicare has informed that the Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30lh June, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×